Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3042]
News [6151]
Articles [120]
Editorials [18]
Conferences [181]
elearning [32]
Long-term disease control in multiple myeloma by in-class transitioning: A...
Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA
Long-term disease control in multiple myeloma by in-class transitioning: A community-based study ( Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA )
3 Jul 2020
Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma
Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma ( Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA )
3 Jul 2020
Treating acute lymphoblastic leukaemia in the era of COVID-19
Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
Treating acute lymphoblastic leukaemia in the era of COVID-19 ( Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA )
3 Jul 2020
Managing acute myeloid leukaemia during the COVID-19 pandemic
Dr Naval Daver - MD Anderson Cancer Center, Houston, USA
Managing acute myeloid leukaemia during the COVID-19 pandemic ( Dr Naval Daver - MD Anderson Cancer Center, Houston, USA )
1 Jul 2020
Meet the Expert: Daniel Seymour
Daniel Seymour - BIO Ventures for Global Health, Seattle, USA
Meet the Expert: Daniel Seymour ( Daniel Seymour - BIO Ventures for Global Health, Seattle, USA )
1 Jul 2020
Gut microbiome disturbance by antibiotic treatment early in life is sufficient...
Dr Carolina Vicente-Dueñas - Institute of Biomedical Research of Salamanca...
Gut microbiome disturbance by antibiotic treatment early in life is sufficient to induce leukaemia in predisposed mice ( Dr Carolina Vicente-Dueñas - Institute of Biomedical Research of Salamanca, Salamanca, Spain )
30 Jun 2020
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial...
Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )
30 Jun 2020
Checkmate 9LA: Nivolumab, ipilimumab and chemotherapy for stage IV NSCLC
Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Checkmate 9LA: Nivolumab, ipilimumab and chemotherapy for stage IV NSCLC ( Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
30 Jun 2020
Treating patients with multiple myeloma in the real world
Dr Ajai Chari and Prof Roman Hájek
Treating patients with multiple myeloma in the real world ( Dr Ajai Chari and Prof Roman Hájek )
26 Jun 2020
ASCEND final results: Acalabrutinib vs idelalisib plus rituximab or...
Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy
ASCEND final results: Acalabrutinib vs idelalisib plus rituximab or bendamustine plus rituximab in R/R CLL ( Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy )
26 Jun 2020
New CAR T therapy for relapsed and refractory ALL
Dr Claire Roddie - University College London, London, UK
New CAR T therapy for relapsed and refractory ALL ( Dr Claire Roddie - University College London, London, UK )
25 Jun 2020
IKEMA: Carfilzomib and dexamethasone plus isatuximab for r/r multiple myeloma
Prof Philippe Moreau - University of Nantes, Nantes, France
IKEMA: Carfilzomib and dexamethasone plus isatuximab for r/r multiple myeloma ( Prof Philippe Moreau - University of Nantes, Nantes, France )
25 Jun 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation